Showing results (211-220 of 302) with videos related to

Sort By:
Pageof 31
Plos One|March 29, 2018
Clinical spectrum and prognostic factors of possible UIP pattern on high-resolution CT in patients who underwent surgical lung biopsyYasuhiro Kondoh, Hiroyuki Taniguchi, Kensuke Kataoka, et al.
BMJ Open Respiratory Research|October 12, 2017
Design of the PF-ILD trial: a double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung diseaseKevin R Flaherty, Kevin K Brown, Athol U Wells, et al.
Clinical & Developmental Immunology|March 26, 2011
Novel prophylactic vaccine using a prime-boost method and hemagglutinating virus of Japan-envelope against tuberculosisMasaji Okada, Yoko Kita, Toshihiro Nakajima, et al.
Respirology (Carlton, Vic.)|February 28, 2022
Predictors of mortality in subjects with progressive fibrosing interstitial lung diseasesKevin K Brown, Yoshikazu Inoue, Kevin R Flaherty, et al.
The European Respiratory Journal|September 3, 2021
Nintedanib in progressive interstitial lung diseases: data from the whole INBUILD trialKevin R Flaherty, Athol U Wells, Vincent Cottin, et al.
Cancer Science|October 8, 2014
Final safety and efficacy of erlotinib in the phase 4 POLARSTAR surveillance study of 10 708 Japanese patients with non-small-cell lung cancerAkihiko Gemma, Shoji Kudoh, Masahiko Ando, et al.
Chest|April 13, 2010
Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseasesLisa R Young, Rhonda Vandyke, Peter M Gulleman, et al.
ERJ Open Research|March 27, 2018
Peripheral alveolar nitric oxide concentration reflects alveolar inflammation in autoimmune pulmonary alveolar proteinosisTaizou Hirano, Shinya Ohkouchi, Naoki Tode, et al.
Orphanet Journal of Rare Diseases|September 1, 2016
Whole lung lavage therapy for pulmonary alveolar proteinosis: a global survey of current practices and proceduresIlaria Campo, Maurizio Luisetti, Matthias Griese, et al.
Pharmacoepidemiology and Drug Safety|July 29, 2017
Risk factors for stomatitis in patients with lymphangioleiomyomatosis during treatment with sirolimus: A multicenter investigator-initiated prospective studyNobutaka Kitamura, Kuniaki Seyama, Yoshikazu Inoue, et al.
Pageof 31